Combination of pegylated interferon‐alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients

A combination of pegylated interferon‐alpha (peg‐IFN‐α) and nucleos(t)ides analogue (NA) therapy can effectively reduce hepatitis B surface antigen (HBsAg), especially in NA‐experienced chronic hepatitis B (CHB) patients. However, the immune mechanism of this therapy is unclear. Forty NA‐experienced...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Exp Immunol
Autors principals: Pang, X., Zhang, L., Liu, N., Liu, B., Chen, Z., Li, H., Chen, M., Peng, M., Ren, H., Hu, P.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2020
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7488124/
https://ncbi.nlm.nih.gov/pubmed/32638357
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13486
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars